Table 4.
Viral interaction of HBV and HCV in HCV/HBV-coinfected patients
|
Study |
Geographic locale |
Sample size (n) |
Baseline HBV DNA (n) |
End of follow-up (n) |
||||||
|---|---|---|---|---|---|---|---|---|---|---|
| |
|
|
|
|
HCV SVR |
Non- HCV SVR |
Baseline HBV DNA positive |
HBV DNA resurgence |
||
| Positive | Negative | HBV VR | Overall | HCV SVR | Non- HCV SVR | |||||
| Yu et al. [35] |
China |
50 |
4 |
46 |
27 |
23 |
4 |
11 |
9 |
2 |
| Liu et al. [32] |
Taiwan |
161 |
76 |
85 |
123 |
38 |
38 |
17 |
NA |
NA |
| Chuang et al. [34] |
Taiwan |
42 |
16 |
26 |
29 |
13 |
5 |
14 |
13 |
1 |
| Hung et al. [30] |
Taiwan |
36 |
18 |
18 |
25 |
11 |
3 |
6 |
4 |
2 |
| Liu et al. [36] | Taiwan | 24 | 20 | 4 | 9 | 15 | 6 | 4 | 2 | 2 |
NA not available, VR virological response (undetectable HBV DNA).